Streetbeat News

Products Services

AVXL

Anavex Life Sciences Corp announced that long-term clinical study results from the U.S. ANAVEX2-73-RS-001 study demonstrate a disease-modifying effect of ANAVEX2-73 (blarcamesine) for adult patients with Rett syndrome. The data shows that blarcamesine exhibited both symptomatic and disease-modifying effects for Rett syndrome in a clinical setting. Despite the positive news, AVXL shares are down 1.67% at $7.95 on the last check Wednesday.

Portfolio Pulse from Vandana Singh

June 28, 2023 | 6:02 pm

BMY

SLS

SELLAS Life Sciences Group Inc (SLS) released topline data from a Phase 1 trial of its lead clinical candidate, galinpepimut-S (GPS), combined with Bristol Myers Squibb Co's (BMY) nivolumab in patients with malignant pleural mesothelioma. The results showed improved survival rates with no dose-limiting toxicities observed. However, SLS shares are down 1.22%.

Portfolio Pulse from Vandana Singh

June 28, 2023 | 6:00 pm

EDSA

Edesa Biotech Inc has released findings from a study involving its monoclonal antibody candidate, paridiprubart, conducted by the University of Toronto. The study found that paridiprubart inhibited inflammation signaling induced by various respiratory pathogens, including Influenza A, coronavirus, and a common bacterium. The company believes that their drug candidate could offer a safe and effective treatment for ARDS caused by coronaviruses, pandemic influenza, and harmful bacteria. EDSA shares are up 5.49% at $0.85.

Portfolio Pulse from Vandana Singh

June 28, 2023 | 5:55 pm

BWV

RHHBY

Blue Water Biotech Inc (NASDAQ:BWV) has released encouraging preclinical data for its monkeypox vaccine candidate, developed using its norovirus shell and protrusion (S&P) virus-like particle (VLP) platform. The vaccine candidate has shown potential in neutralizing the vaccinia virus, which is closely related to monkeypox. Meanwhile, Roche Holdings AG's (OTC:RHHBY) cobas MPXV has received FDA Emergency Use Authorization for detecting monkeypox DNA.

Portfolio Pulse from Vandana Singh

June 28, 2023 | 5:51 pm

DASH

DoorDash Inc (NYSE:DASH) has announced major updates to its consumer app and new options for its workers, known as Dashers. The app updates, based on customer feedback, aim to improve convenience and reliability, and include expanded grocery and retail delivery options, a universal search feature, a browse tab, and a multiple carts option. Dashers now have the option to choose how they earn their pay: by offer or by time. The changes are expected to roll out gradually over the next few months.

Portfolio Pulse from Adam Eckert

June 28, 2023 | 5:47 pm

NFLX

PARA

PARAA

Netflix Inc (NASDAQ:NFLX) has added the film 'Titanic' back to its library, causing outrage among fans due to the timing of the addition, which coincides with a recent tragic submarine disaster at the Titanic wreckage site. The licensing deal for the movie to air on Netflix was struck months in advance. The film is one of the most well-known titles of Paramount Global (NASDAQ:PARA)(NASDAQ:PARAA).

Portfolio Pulse from Chris Katje

June 28, 2023 | 5:28 pm

VIRX

Viracta Therapeutics Inc (NASDAQ:VIRX) announced that their pivotal NAVAL-1 clinical trial for relapsed or refractory EBV+ peripheral T-cell lymphoma (R/R EBV+ PTCL) has met the pre-specified efficacy threshold for advancement to Stage 2. The decision is based on achieving a predetermined minimum number of objective responses within the first ten enrolled patients. The company's shares are up 5.5% at $1.51.

Portfolio Pulse from Vandana Singh

June 28, 2023 | 4:52 pm

ASTS

CGTX

KLR

NERV

SONN

TOVX

US stocks traded mixed with the Nasdaq Composite gaining over 80 points. U.S. crude oil inventories dropped by 9.603 million barrels, more than the market estimates of a 1.757 million decline. Kaleyra, Inc. (KLR), Minerva Neurosciences, Inc. (NERV), and Theriva Biologics, Inc. (TOVX) saw their shares rise after various positive announcements. Meanwhile, AST SpaceMobile, Inc. (ASTS), Sonnet BioTherapeutics Holdings, Inc. (SONN), and Cognition Therapeutics, Inc. (CGTX) saw their shares drop due to various negative announcements.

Portfolio Pulse from Lisa Levin

June 28, 2023 | 4:22 pm

MNMD

HC Wainright has released a note stating that Mind Medicine's MM-120 appears ready to excel in Phase 2b Anxiety Trial. They believe the underappreciated MM-120 could become a blockbuster anxiety treatment and have given the company a buy rating with a $75 price target.

Portfolio Pulse from Happy Mohamed

June 28, 2023 | 4:17 pm

GOOG

The article lists the top 10 cannabis shops in San Francisco, based on Google's star ratings. The ratings are derived from consumer reviews. The shops offer a variety of cannabis products for both medical and recreational use. The article also mentions the Benzinga Cannabis Capital Conference, a major cannabis business event.

Portfolio Pulse from Jelena Martinovic

June 28, 2023 | 3:49 pm